1. Purity and Consistency:
* Recombinant insulin: Produced in bacteria or yeast cells, it is highly pure and consistent in its composition and activity. This ensures predictable and reliable effects in patients.
* Animal insulin: Extracted from animal pancreases, it can contain impurities, variations in potency, and potential allergens. This can lead to inconsistent effects and adverse reactions.
2. Ethical Considerations:
* Recombinant insulin: Does not involve animal slaughter, addressing ethical concerns about animal welfare.
* Animal insulin: Requires the harvesting of pancreases from animals, raising ethical questions about animal treatment.
3. Availability and Scalability:
* Recombinant insulin: Can be produced in large quantities, ensuring consistent and readily available supply.
* Animal insulin: Supply is limited by the availability of animal pancreases, making it prone to shortages and price fluctuations.
4. Safety:
* Recombinant insulin: Minimizes the risk of transmitting animal diseases to humans, as it does not involve animal products.
* Animal insulin: There is a small risk of transmitting animal pathogens to humans.
5. Cost:
* Recombinant insulin: Production costs have decreased significantly over time, making it more affordable than animal-derived insulin.
* Animal insulin: Extraction and purification processes are expensive, making it more costly.
6. Patient Tolerance:
* Recombinant insulin: Human insulin is well-tolerated by most patients, with minimal risk of allergic reactions.
* Animal insulin: Can trigger allergic reactions in some individuals due to the presence of foreign proteins.
7. Customization:
* Recombinant insulin: Allows for the development of various insulin analogs with modified properties, like faster or slower action, improving diabetic management.
* Animal insulin: Offers limited flexibility in terms of modifying insulin properties.
In conclusion, recombinant DNA technology offers a superior solution for insulin production compared to extraction from animals, providing a safe, ethical, and cost-effective way to treat diabetes.
